课题基金 / 基金详情

Stem Cell Therapy for Sensorineural Hearing Loss - How Do Glial Cells Interact With Auditory Stem Cells in the Peripheral Auditory System?

Stem Cell Therapy for Sensorineural Hearing Loss - How Do Glial Cells Interact With Auditory Stem Cells in the Peripheral Auditory System?
干细胞疗法治疗感音神经性听力损失 - 神经胶质细胞如何与周围听觉系统中的听觉干细胞相互作用?
批准号:
MR/L001829/1
负责人:
Ali Mallick
金额:
$27.18万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
研究的临床背景听力问题是一个极其重要的公共卫生问题。英国有近1000万人患有听力障碍,预测显示,到2030年,这一数字将上升到1500万。感觉神经性听力损失占所有听力问题的近90%,是由于内耳受到不可逆转的损害,尤其是耳蜗,声音的振动会转化为神经信号。虽然电子设备,如人工耳蜗,已经成功地帮助所有年龄段的严重感音神经性听力损失的患者,但这种设备的局限性正逐渐显现。再生医学为生物疗法带来了一些希望,这种疗法可能能够比目前使用电子设备进行的治疗更有效地治疗感音神经性听力损失。在最近的一项重大突破中,我们的实验室在感音神经性耳聋的动物模型中证明了干细胞修复和恢复受损听神经功能的能力。这个项目将建立在我们之前工作的基础上,通过了解干细胞如何与受损的听力系统整合。这项研究的重要性“胶质细胞”是指维持神经细胞健康的细胞。众所周知,神经损伤会导致神经胶质细胞的激活和增殖。在神经系统的某些部分,这种神经胶质细胞的增殖过程有助于受损神经的修复,但在其他部分,如大脑和脊髓,胶质细胞的增殖形成了疤痕,这限制了对神经的进一步损害,但也阻止了修复。最近发现,听力神经的损伤也会导致神经胶质细胞的增殖,但目前尚不清楚这是否代表了一种支持修复的环境,或者是否代表了疤痕形成。这显然会对干细胞修复受损听力神经的能力产生影响。因此,了解听力系统的神经胶质细胞和干细胞之间的关系是寻求将这种疗法推广到患者身上的关键因素。本研究的目的是了解干细胞与神经胶质细胞沟通的方式,并阐明神经胶质细胞对听神经损伤的反应是否代表了瘢痕形成,或者它是否代表了干细胞修复听神经的有利环境。然后,我们将在耳聋动物模型中演示移植的听觉干细胞如何与神经胶质细胞整合。研究计划该项目将分两个阶段进行。第一阶段将包括培养干细胞,为听觉系统编程,以检查它们是否有能力产生自己的胶质样细胞。然后,干细胞将与耳蜗神经胶质细胞一起培养,这将允许研究这两种细胞类型之间的相互作用。第二阶段将包括确定干细胞是否能够修复受损的听神经,尽管胶质细胞增殖。这将涉及对受损的听神经中的胶质细胞类型以及干细胞如何与它们相互作用进行仔细的分析。从前一阶段收集的信息将有助于描述这种关系。主办机构该项目将在谢菲尔德大学干细胞生物学中心进行,该中心是国际公认的干细胞研究的卓越中心。该中心率先将干细胞用于内耳,并拥有实施这一项目的所有必要设施。
英文摘要
Clinical Background of ResearchHearing problems are an extremely significant public health issue. Almost 10 million people in Britain suffer with hearing impairment and forecasts suggest this will rise to 15 million by the year 2030. 'Sensorineural hearing loss' accounts for almost 90% of all hearing problems and occurs as a result of irreversible damage to the inner ear, especially the cochlea, where sound vibrations are converted into nerve signals. Although electrical devices such as Cochlear Implants have been used successfully to help patients of all ages suffering with severe sensorineural hearing loss, the limitations of such devices are gradually becoming apparent. Regenerative medicine provides some hope of biological therapies which may be able to treat sensorineural hearing loss with greater effect than current treatments with electrical devices. In a recent major breakthrough, our laboratory has demonstrated the ability of stem cells to repair and restore function of damaged hearing nerves in animal models of sensorineural hearing loss. This project will build on our previous work by understanding how stem cells integrate with a damaged hearing system. Importance of this Research'Glial Cells' are cells which maintain the health of nerve cells. It is well known that nerve damage results in the activation and multiplication of 'glial cells'. In some parts of the nervous system, this process of glial cell multiplication can help with the repair of damaged nerves, but in other parts, such as the brain and spinal cord, the multiplication of glial cells represents scarring which limits further damage to nerves, but also prevents repair. It has recently been discovered that damage to the hearing nerve also causes multiplication of glial cells, but it remains unclear if this represents an environment which would either support repair or whether it represents scarring. This would obviously have implications on the ability for stem cells to repair the damaged hearing nerve. Hence, understanding the relationship between the glial cells of the hearing system and stem cells is a key factor in the quest to translate this therapy to patients. Aims of this ResearchThe aims of this project are to understand the ways in which stem cells communicate with glial cells, and to illustrate whether the response of glial cells to damage of the hearing nerve represents scarring, or whether it represents a favourable environment for and stem cells to repair the hearing nerve. We will then demonstrate how transplanted auditory stem cells integrate with glial cells in animal models of deafness. Research PlanThe project will be conducted in two phases. The first phase will consist of culturing stem cells programmed for the auditory system to check if they are capable of producing their own glial-like cells. The stem cells will then be cultured alongside glial cells from the cochlea, which will allow the interaction between the two cell types to be studied. The second phase will consist of determining whether stem cells are able to repair the damaged hearing nerve despite the multiplication of glial cells. This will involve performing careful analysis of the glial cell types in the damaged hearing nerve and how stem cells interact with them. The information gathered from the previous phase will help in describing this relationship. Host InstitutionThis project will be undertaken at the Centre for Stem Cell Biology at the University of Sheffield which has international recognition as a centre of excellence for research into Stem Cells. The centre has pioneered the use of stem cells to the inner ear and has all the necessary facilities to carry out this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
  • 批准号:
    82305053
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王丽明
  • 依托单位: